Oyan Basak, Koc Yener, Emri Salih, Kansu Emin
Department of Medical Oncology, Institute of Oncology, Hacettepe University, Ankara 06100, Turkey.
Med Oncol. 2006;23(1):125-9. doi: 10.1385/MO:23:1:125.
Despite use of combined immunosuppressive agents, prognosis of patients developing pulmonary manifestations of chronic graft-vs-host disease (cGVHD) following allogeneic stem cell transplantation (SCT) still remains poor. We present a male patient who developed pulmonary cGVHD in the form of bronchiolitis obliterans organizing pneumonia (BOOP) following allogeneic SCT for acute myelogenous leukemia. The patient developed progressive course despite use of a combination of immunosuppressive agents including high-dose prednisone, cyclosporin-A, and mycophenolate mofetil in addition to steroid-related complications. A remarkable clinical response to extracorporeal photopheresis (ECP) was observed, allowing minimization of immunosuppressive therapy and discontinuation of cyclosporin-A. Pulmonary functions and carbon monoxide diffusion capacity (DLCO) gradually improved and stabilized, but did not return to pretransplant baseline levels.
尽管使用了联合免疫抑制剂,但异基因干细胞移植(SCT)后出现慢性移植物抗宿主病(cGVHD)肺部表现的患者预后仍然很差。我们报告一名男性患者,他在接受急性髓性白血病异基因SCT后,以闭塞性细支气管炎伴机化性肺炎(BOOP)的形式出现了肺部cGVHD。尽管使用了包括大剂量泼尼松、环孢素A和霉酚酸酯在内的联合免疫抑制剂,且出现了与类固醇相关的并发症,但患者病情仍呈进行性发展。观察到患者对体外光化学疗法(ECP)有显著的临床反应,从而使免疫抑制治疗得以最小化,并停用了环孢素A。肺功能和一氧化碳弥散量(DLCO)逐渐改善并稳定,但未恢复到移植前的基线水平。